Perform Another (Advanced) Search

1.  Study Posting (1768) Trial #65525, Prostate Cancer, Staten Island, NY
...Currently being treated for prostate cancer with androgen deprivation therapy or have undergone a bilateral orchiectomy. • Are willing to participate in the full 2 years of the trial. Qualified participants will ...
View Page

2.  Study Posting (77) Trial #137471, Prostate Cancer, Bronx, NY
...nervous system cancer or spinal cancer. • Have urinary tract obstruction. • Have a history of bilateral orchiectomy, adrenalectomy, hypophysectomy or hypogonadism. • Have current malignancy or history of malignancy within 5 years prior ...
View Page

3.  Newly Approved Drug Therapies (622) Trelstar Depot (triptorelin pamoate), Debio Rechereche Pharmaceutique, Target Research Associates,
...palliative treatment of advanced prostate cancer. It offers an alternative treatment for prostate cancer when orchiectomy or estrogen administration are either not indicated, or unacceptable to the patient. Clinical Results Following ...
View Page

4.  Newly Approved Drug Therapies (38) Zoladex (10.8 mg goserelin acetate implant), AstraZeneca,
...analogue. The 3.6 mg formulation of Zoladex was shown to be as effective as orchiectomy (surgical castration) in controlling the spread of prostate cancer, thus offering men a choice between ...
View Page

5.  Study Posting (1918) Trial #159850, Prostate Cancer, Savannah, GA
...androgen deprivation for treatment or control of prostate cancer including any of the following: • Bilateral orchiectomy • Luteinizing hormone-releasing hormone (LHRH) agonist therapy (e.g., leuprolide, goserelin, bicalutamide, flutamide, or similar ...
View Page

6.  Study Posting (1918) Trial #159849, Hot Flash, Savannah, GA
...androgen deprivation for treatment or control of prostate cancer including any of the following: • Bilateral orchiectomy • Luteinizing hormone-releasing hormone (LHRH) agonist therapy (e.g., leuprolide, goserelin, bicalutamide, flutamide, or similar ...
View Page

7.  Study Posting (3693) Trial #70957, Solid Tumors, Baltimore, MD
...antiandrogen medication and no evidence of response to treatment • Luprolide should continue if no prior orchiectomy • No prior or concurrent brain metastases PATIENT CHARACTERISTICS: Performance status: • ECOG 0 or 1: Ambulatory ...
View Page

8.  Newly Approved Drug Therapies (846) Plenaxis (abarelix for injectable suspension), Praecis Pharmaceuticals,
...open-label, multicenter, uncontrolled, single-arm study was designed to see if patients could avoid orchiectomy through at least 12 weeks of treatment. Treatment was given for at least 6 months ...
View Page